vimarsana.com

StockNews.com upgraded shares of Elevance Health (NYSE:ELV – Free Report) from a buy rating to a strong-buy rating in a research note published on Monday morning. Other equities research analysts also recently issued reports about the company. Wells Fargo & Company increased their price target on Elevance Health from $557.00 to $600.00 and gave the […]

Related Keywords

United States ,Canada ,Feliciaf Norwood , ,Norges Bank ,News Ratings For Elevance Health Daily ,Elevance Health ,Sanders Capital ,Elevance Health Company Profile ,Royal Bank ,Analyst Recommendations For Elevance Health ,Capital International Investors ,Carelon Services ,Elevance Health Trading ,Wells Fargo Company ,Hedge Funds Weigh In On Elevance Health ,Elevance Health Dividend Announcement ,Morgan Stanley ,Baillie Gifford Co ,Elevance Health Inc ,Cantor Fitzgerald ,Free Report ,Get Free Report ,International Investors ,Health Benefits ,Elevance Health Daily ,

© 2024 Vimarsana

vimarsana.com © 2020. All Rights Reserved.